x

Pesquisar um ensaio clínico

* (*) campo(s) de preenchimento obrigatório

127 Resultado(s)

Ordenados por

Ensaio em fase de recrutamento = Ensaio em fase de recrutamento; Ensaio a decorrer = Ensaio a decorrer; Financiado por um membro do IRDiRC =

Ensaio (s) clínico (s) nacional (is)

ALEMANHA

Baden-Württemberg
HEIDELBERG

ALEMANHA

Baden-Württemberg
HEIDELBERG

ALEMANHA

Baden-Württemberg
HEIDELBERG

ALEMANHA

Baden-Württemberg
ULM

ALEMANHA

Bayern
MÜNCHEN

Ensaio em fase de recrutamentoEnsaio a decorrerGlioCave/NOA17: Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma (Phase 2) - DE
Klinikum rechts der Isar der Technischen Universität München
Klinik und Poliklinik für RadioOnkologie und Strahlentherapie

ALEMANHA

Hessen
FRANKFURT AM MAIN

AUSTRIA

WIEN
WIEN

ESPANHA

Cataluña
BARCELONA

ESPANHA

Cataluña
ESPLUGUES DE LLOBREGAT

ESPANHA

Navarra
PAMPLONA

Phase II study of neoadjuvant nivolumab in patients with glioblastoma multiforme - ES (completed)
CIMA - Centro de Investigación Médica Aplicada
Área de Terapia Génica y Hepatología

FRANCA

AUVERGNE-RHONE-ALPES
BRON

Ensaio em fase de recrutamentoEnsaio a decorrerRandomized, Prospective, Multicenter Blinding Singles With Arm A and Arm B Innovative Strategy Strategy Conventional (Phase III) - FR
CHU de Lyon HCL - GH Est-Hôpital Neurologique P. Wertheimer
Neurochirurgie B - Unité multidisciplinaire de Chirurgie Tumorale de la base du Crâne

FRANCA

BRETAGNE
RENNES

FRANCA

ILE-DE-FRANCE
BOBIGNY

A Phase II multicenter study of immunotherapy with CpG-ODN in patients with glioblastoma -Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCA

ILE-DE-FRANCE
BOBIGNY

Randomized Phase III Open Label Study - Enzastaurin vs. Lomustine in Glioblastoma - Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCA

ILE-DE-FRANCE
BOBIGNY

Glivec - Hydrea in recurrent glioblastoma (Phase II) - Terminated -
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCA

ILE-DE-FRANCE
BOBIGNY

Ensaio em fase de recrutamentoRadiotherapy and Temozolomide with or without Avastin for treatment of de novo glioblastoma (Phase III)
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de neurologie

FRANCA

ILE-DE-FRANCE
PARIS

EORTC protocol 26083 : Randomized phase II of CCNU (Lomustine) versus CCNU (Lomustine) - dasatinib in patients with recurrent glioblastoma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Unité Fonctionnelle Epilepsie

FRANCA

ILE-DE-FRANCE
PARIS

Chemotherapy study of temozolomide-bevacizumab treatment of supratentorial glioblastoma patients more than 70 years old with altered functional state (Phase II).
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Département de Neurologie 2 (Mazarin) : Neuro-Oncologie

FRANCA

ILE-DE-FRANCE
PARIS

Phase III study chemotherapy vs radiotherapy in low-grade glioma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Département de Neurologie 2 (Mazarin) : Neuro-Oncologie

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio em fase de recrutamentoEnsaio a decorrerA Prospective, Multi-center Phase III Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed Glioblastoma Multiforme
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Département de Neurologie 2 (Mazarin) : Neuro-Oncologie

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio em fase de recrutamentoMulticentric Randomized Phase II: Immunotherapy With CpG-ODN in Malignant Glioblastoma
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Consultation de Neurochirurgie

FRANCA

OCCITANIE
TOULOUSE

PhaseI-II trial to assess the radiosensitizing effect of Zarnestra in patients with glioblastoma multiforme
IUCT Oncopole - CLCC Institut Claudius Regaud
Département de radiothérapie

FRANCA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

A randomized multicentric phase II trial immunotherapy of de novo glioblastoma by CpG-ODN
CHU de Marseille - Hôpital de la Timone
Service de neuro-oncologie

PAISES BAIXOS

Limburg
MAASTRICHT

PAISES BAIXOS

Noord-Holland
AMSTERDAM

REINO UNIDO

Greater London
LONDON

SUICA

Suisse Alémanique
ZÜRICH

Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma (ARTE)
University Hospital Zurich
Department of Neurology

ESPANHA

Cataluña
ESPLUGUES DE LLOBREGAT

ALEMANHA

Bayern
REGENSBURG

ALEMANHA

Nordrhein-Westfalen
BONN

ALEMANHA

Niedersachsen
GÖTTINGEN

FRANCA

AUVERGNE-RHONE-ALPES
LYON

FRANCA

ILE-DE-FRANCE
PARIS

Ensaio em fase de recrutamentoEnsaio a decorrerA Study Evaluating Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia. A Phase III Double-blind Randomized Placebo-controlled Trial
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Unité Fonctionnelle Epilepsie

FRANCA

ILE-DE-FRANCE
VILLEJUIF

Ensaio em fase de recrutamentoEnsaio a decorrerBIOMEDE: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication (Phase II) - FR
CLCC Institut Gustave Roussy
Département de cancérologie de l'enfant et de l'adolescent #

FRANCA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

PAISES BAIXOS

Zuid-Holland
LEIDSCHENDAM

Cognitive Rehabilitation of Glioma Patients
HMC - Haaglanden Medisch Centrum, locatie Antoniushove
Polikliniek Neurologie

REINO UNIDO

Tyne & Wear
NEWCASTLE UPON TYNE

CNS 2007 04: A Phase II Multi-Centre Study of Concomitant and Prolonged Adjuvant Temozolomide With Radiotherapy in Diffuse Pontine Gliomas - UK (Completed)
The Great North Children's Hospita, Royal Victoria Infirmary
Sir James Spence Institute of Child Health

REINO UNIDO

Greater Manchester
NOT YET IDENTIFIED - UK

Ensaio (s) clínico (s) multinacional (ais)

ALEMANHA

Baden-Württemberg
TÜBINGEN